Mimicking Fetal (Parallel) Circulation

In postnatal series physiology, RV and LV carry the same flow (Qp = Qs); failure of either ventricle compromises the entire circuit. In selected neonatal conditions, recreating a parallel, fetal-like pattern deliberately uncouples Qp from Qs so that RV and LV share systemic work. The strategy hinges on two anatomic conduits—a patent ductus arteriosus (PDA) and a non-restrictive atrial communication (ASD/PFO)—and on physiologic tuning of PVR/SVR to direct streams to the most effective ventricle [1, 2].

Physiologic goals and indications

The goals are to (i) preserve systemic oxygen delivery (DO₂) while accepting lower saturations, (ii) reduce single-ventricle stress when one ventricle or outflow tract is inadequate, and (iii) provide a stable bridge to definitive repair or staged palliation. Typical indications include ductal-dependent systemic or pulmonary blood flow (critical AS, severe CoA/IAA; pulmonary atresia/critical PS), and single-ventricle pathways before Glenn/Fontan, where routing rather than complete mixing determines oxygenation [1, 2].

How the parallel pattern is created

1. Maintain PDA flow. Low-dose PGE₁ or ductal stenting preserves a low-resistance PA–Ao connection; the direction (PA→Ao vs Ao→PA) follows PVR/SVR and proximal obstructions [1–3].
2. Guarantee interatrial egress. Balloon atrial septostomy or septectomy prevents pulmonary venous/RA hypertension and permits redistribution of venous return to the better ventricle [3].
3. Steer the circuit with physiology. Ventilation, FiO₂, and PaCO₂ are adjusted to raise or lower PVR; vasoactive therapy shapes SVR so that ductal and atrial streams preferentially support the target beds (e.g., PA→Ao for descending aorta; Ao→PA if pulmonary flow is the limiting factor) [1, 2].

PDA stent versus surgical shunt

Evidence comparing PDA stenting with systemic-to-pulmonary shunts shows a consistent trade-off: PDA stenting is associated with lower early mortality, shorter ICU/hospital stay, less vasoactive support, and better symmetric PA growth, but with higher reintervention rates during follow-up [4–6]. Center expertise and ductal anatomy should drive the choice.

Monitoring and targets

Bedside guidance relies on pre-/post-ductal SpO₂ and cerebral/renal NIRS to detect differential oxygenation as flows redistribute [6]. Echocardiography confirms ductal patency, flow direction/magnitude, atrial patency, and ventricular performance. Clinically, titrate toward a balanced Qp:Qs (often near 1:1), avoiding systemic steal (excess Ao→PA runoff) and pulmonary overcirculation—problems that are physiologic, not purely anatomic [7].

Risks and countermeasures

• Systemic steal / hypotension. Reduce PGE₁, cautiously raise SVR, or limit ductal caliber; reconsider anatomy for proximal obstruction [7].
• Pulmonary overcirculation. Increase PVR (ventilator adjustments), diurese, or down-size the ductal conduit to protect systemic DO₂ [7].
• Desaturation by design. Accept lower SaO₂ if end-organ perfusion is adequate; treat the DO₂ equation, not the number alone [1, 7].
• Reintervention after stenting. Anticipate scheduled re-catheterization for ductal growth or restenosis; this is the price of the less invasive initial strategy [4–6].

Transition back to series circulation

Move away from the parallel configuration when the failing ventricle recovers, the obstruction is relieved, or the patient is ready for staged cavopulmonary palliation, which ultimately converts the parallel layout to a series circuit via Glenn/Fontan connections [2]. Practical cues include stable or improving lactate, adequate blood pressure/urine output, acceptable NIRS, and echocardiographic evidence of ventricular reserve with minimal shunt dependence.

Summary

Mimicking fetal circulation is a deliberate, physiology-first strategy: keep the ductus open, ensure a non-restrictive ASD, and tune PVR/SVR so RV and LV share systemic work. For ductal-dependent lesions and early single-ventricle care, it stabilizes perfusion and buys time for recovery or definitive surgery. Current evidence supports PDA stenting as an effective alternative to surgical shunts—often with better early recovery but more reinterventions—and emphasizes meticulous monitoring and titration to avoid systemic steal and pulmonary overcirculation [1–7].

References

[1] Friedman WF, Fahey JT. Fetal–neonatal circulatory physiology and implications for congenital heart disease. Review. 1993.

[2] Walker SG, Stuth EA. Principles of parallel (fetal-like) circulation and staged palliation in neonates with congenital heart disease. Review. 2004.

[3] Deshpande SR, et al. Interatrial communication and ductal strategies to maintain parallel circulation in neonates. Review. 2018.

[4] Glatz AC, et al. Patent ductus arteriosus stenting versus surgical shunt for ductal-dependent pulmonary blood flow—comparative outcomes. Review. 2017.

[5] Bauser-Heaton H, et al. PDA stenting in neonates and infants with ductal-dependent pulmonary blood flow: early outcomes and reintervention profile. Review. 2022.

[6] Sheth S, Loomba RS. Ductal stenting as first-stage palliation: monitoring with pre/post-ductal oximetry and NIRS. Review. 2022.

[7] Haller C, Barron DJ. Balancing Qp:Qs and avoiding systemic steal in parallel circulation—practical guidance. Review. 2022.